Large-scale cell production of stem cells for clinical application using the automated cell processing machine

BMC Biotechnology

Volumn 13, Issue , 2013, Pages

  Kami, Daisuke ^a   Watakabe, Keizo ^b   Yamazaki Inoue, Mayu ^c   Minami, Kahori ^c   Kitani, Tomoya ^a   Itakura, Yoko ^d   Toyoda, Masashi ^d   Sakurai, Takashi ^b   Umezawa, Akihiro ^c   Gojo, Satoshi ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KAWASAKI HEAVY INDUSTRIES LTD   (Japan)

^c NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^d TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

Automated cell culture system; Cell processing facility; Cell transplantation; Clinical trial; Stem cells

Indexed keywords

AUTOMATION; CELL CULTURE; CELL MEMBRANES; EXPERIMENTS; FLOW CYTOMETRY; GENE EXPRESSION; MEDICAL APPLICATIONS; MEDICINE; ROBOTICS;

CELL PROCESSING; CELL TRANSPLANTATION; CLINICAL TRIAL; CULTURE SYSTEMS; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION PROFILES; LARGE-SCALE PRODUCTION; REGENERATIVE MEDICINE;

STEM CELLS;

BETA1 INTEGRIN; CD45 ANTIGEN; ENDOGLIN; GENOMIC DNA; GLYCAN; LECTIN; OCTAMER TRANSCRIPTION FACTOR 4; THY 1 ANTIGEN; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR REX 1; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

ARTICLE; AUTOMATED CELL PROCESSING MACHINE; AUTOMATION; BARE LYMPHOCYTE SYNDROME; CELL GROWTH; CELL REGENERATION; CELL STRUCTURE; CELL SURFACE; CELL THERAPY; CLINICAL MEDICINE; CLINICAL TRIAL (TOPIC); CULTURE MEDIUM; ENZYME STABILITY; FEASIBILITY STUDY; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION PROFILING; GROWTH RATE; HUMAN; HUMAN CELL; LARGE SCALE CELL PRODUCTION; LARGE SCALE PRODUCTION; PHOTOGRAPHY; REGENERATIVE MEDICINE; ROBOTICS; STEM CELL; STEM CELL CULTURE; TRANSCRIPTION FACTOR REX 2;

AGED; AUTOMATION, LABORATORY; CELL CULTURE TECHNIQUES; CELL- AND TISSUE-BASED THERAPY; COMPARATIVE GENOMIC HYBRIDIZATION; FLOW CYTOMETRY; HEART ATRIA; HUMANS; MEMBRANE PROTEINS; POLYSACCHARIDES; PROTEIN ARRAY ANALYSIS; REPRODUCIBILITY OF RESULTS; ROBOTICS; STEM CELLS; TRANSCRIPTOME;

EID: 84887513924     PISSN: None     EISSN: 14726750     Source Type: Journal    
DOI: 10.1186/1472-6750-13-102     Document Type: Article

References (30)

1. Takehara N, Tsutsumi Y, Tateishi K, Ogata T, Tanaka H, Ueyama T, Takahashi T, Takamatsu T, Fukushima M, Komeda M, et al. Controlled delivery of basic fibroblast growth factor promotes human cardiosphere-derived cell engraftment to enhance cardiac repair for chronic myocardial infarction. J Am Coll Cardiol 2008, 52(23):1858-1865. 10.1016/j.jacc.2008.06.052, 19038683.
2. Smith RR, Barile L, Cho HC, Leppo MK, Hare JM, Messina E, Giacomello A, Abraham MR, Marban E. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 2007, 115(7):896-908. 10.1161/CIRCULATIONAHA.106.655209, 17283259.
3. Rota M, Padin-Iruegas ME, Misao Y, De Angelis A, Maestroni S, Ferreira-Martins J, Fiumana E, Rastaldo R, Arcarese ML, Mitchell TS, et al. Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function. Circ Res 2008, 103(1):107-116. 10.1161/CIRCRESAHA.108.178525, 2747796, 18556576.
4. Vogel G. Stem cells for sale. Science 2010, 330(6008):1173. 10.1126/science.330.6008.1173, 21109646.
5. Tran CA, Burton L, Russom D, Wagner JR, Jensen MC, Forman SJ, DiGiusto DL. Manufacturing of large numbers of patient-specific T cells for adoptive immunotherapy: an approach to improving product safety, composition, and production capacity. J Immunother 2007, 30(6):644-654. 10.1097/CJI.0b013e318052e1f4, 17667528.
6. Soncin S, Lo Cicero V, Astori G, Soldati G, Gola M, Surder D, Moccetti T. A practical approach for the validation of sterility, endotoxin and potency testing of bone marrow mononucleated cells used in cardiac regeneration in compliance with good manufacturing practice. J Transl Med 2009, 7:78. 10.1186/1479-5876-7-78, 2753319, 19737416.
7. Joannides A, Fiore-Heriche C, Westmore K, Caldwell M, Compston A, Allen N, Chandran S. Automated mechanical passaging: a novel and efficient method for human embryonic stem cell expansion. Stem Cells 2006, 24(2):230-235. 10.1634/stemcells.2005-0243, 16510428.
8. Kino-Oka M, Ogawa N, Umegaki R, Taya M. Bioreactor design for successive culture of anchorage-dependent cells operated in an automated manner. Tissue Eng 2005, 11(3-4):535-545.
9. Terstegge S, Laufenberg I, Pochert J, Schenk S, Itskovitz-Eldor J, Endl E, Brustle O. Automated maintenance of embryonic stem cell cultures. Biotechnol Bioeng 2007, 96(1):195-201. 10.1002/bit.21061, 16960892.
10. Thomas RJ, Anderson D, Chandra A, Smith NM, Young LE, Williams D, Denning C. Automated, scalable culture of human embryonic stem cells in feeder-free conditions. Biotechnol Bioeng 2009, 102(6):1636-1644. 10.1002/bit.22187, 19062183.
11. Koike H, Kubota K, Sekine K, Takebe T, Ouchi R, Zheng YW, Ueno Y, Tanigawa N, Taniguchi H. Establishment of automated culture system for murine induced pluripotent stem cells. BMC Biotechnol 2012, 12:81. 10.1186/1472-6750-12-81, 3499150, 23127273.
12. Thomas RJ, Chandra A, Liu Y, Hourd PC, Conway PP, Williams DJ. Manufacture of a human mesenchymal stem cell population using an automated cell culture platform. Cytotechnology 2007, 55(1):31-39. 10.1007/s10616-007-9091-2, 2289788, 19002992.
13. Hubbell JA, Palsson BO, Papoutsakis ET. Preface: tissue engineering and cell therapies: II. Biotechnol Bioeng 1994, 43(8):683. 10.1002/bit.260430802, 18615791.
14. Thomas R, Chandra A, Hourd P, Williams D. Cell culture automation and quality engineering: a necessary partnership to develop optimized manufacturing processes for cell-based therapies. J Assoc Lab Autom 2008, 13(3):152-158.
15. Thomas RJ, Hourd PC, Williams DJ. Application of process quality engineering techniques to improve the understanding of the in vitro processing of stem cells for therapeutic use. J Biotechnol 2008, 136(3-4):148-155.
16. Takehara N, Ogata T, Nakata M, Kami D, Nakamura T, Matoba S, Gojo S, Sawada T, Yaku H, Matsubara H. The ALCADIA (Autologous Human Cardiac-Derived Stem Cell to Treat Ischemic Cardiomyopathy) trial 2012, 19106-3621. PHILADELPHIA, PA: LIPPINCOTT WILLIAMS & WILKINS 530 WALNUT ST, Circulation, USA: 2783-2783.
17. Toyoda M, Yamazaki-Inoue M, Itakura Y, Kuno A, Ogawa T, Yamada M, Akutsu H, Takahashi Y, Kanzaki S, Narimatsu H, et al. Lectin microarray analysis of pluripotent and multipotent stem cells. Genes Cells 2011, 16(1):1-11. 10.1111/j.1365-2443.2010.01459.x, 21155951.
18. Sharov AA, Dudekula DB, Ko MS. A web-based tool for principal component and significance analysis of microarray data. Bioinformatics 2005, 21(10):2548-2549. 10.1093/bioinformatics/bti343, 15734774.
19. Ptaszek LM, Mansour M, Ruskin JN, Chien KR. Towards regenerative therapy for cardiac disease. Lancet 2012, 379(9819):933-942. 10.1016/S0140-6736(12)60075-0, 22405796.
20. Gojo S, Toyoda M, Umezawa A. Tissue engineering and cell-based therapy toward integrated strategy with artificial organs. J Artif Organs 2011, 14(3):171-177. 10.1007/s10047-011-0578-4, 21660420.
21. Liu Y, Hourd P, Chandra A, Williams DJ. Human cell culture process capability: a comparison of manual and automated production. J Tissue Eng Regen Med 2010, 4(1):45-54.
22. Kuroda Y, Kitada M, Wakao S, Nishikawa K, Tanimura Y, Makinoshima H, Goda M, Akashi H, Inutsuka A, Niwa A, et al. Unique multipotent cells in adult human mesenchymal cell populations. Proc Natl Acad Sci USA 2010, 107(19):8639-8643. 10.1073/pnas.0911647107, 2889306, 20421459.
23. Unger C, Skottman H, Blomberg P, Dilber MS, Hovatta O. Good manufacturing practice and clinical-grade human embryonic stem cell lines. Human Mol Genet 2008, 17(R1):R48-R53.
24. Allport-Settle MJ. Good Manufacturing Practice (GMP) Guidelines 2009, Raleigh: Pharmalogika.
25. Burger SR. Current regulatory issues in cell and tissue therapy. Cytotherapy 2003, 5(4):289-298. 10.1080/14653240310002324, 12944234.
26. USP 32-NF 27 Cell and gene therapy products 2008, United States Pharmacopeia, Rockville: Manufacturing of cell therapy products, USP.
27. Niazi SK. Sterile products, vol. 6 2009, London: Informa Healthcare Inc.
28. Takehara NOT, Nakata M, Kami D, Matoba NT, Gojo S, Sawada T, Yaku H, Matsubara H. The ALCADIA (autologous Human Cardiac-derived Stem Cell To Treat Ischemic Cardiomyopathy) Trial 2012, Los Angeles: American Heart Association, Scientific Session, Late Breaking Clinical Trial Application.
29. Kuno A, Itakura Y, Toyoda M, Takahashi Y, Yamada M, Umezawa A, Hirabayashi J. Development of a data-mining system for differential profiling of cell glycoproteins based on lectin microarray. J Proteom Bioinfo 2008, 1(2):5.
30. Itakura Y, Kimura M, Gojo S, Toyoda M, Kami D, Motomura N, Umezawa A, Kyo S, Ono M. Glycan profiling using a lectin microarray is a novel validation tool for monitoring the damage to freeze-thawed cells. Low Temp Med 2011, 37:7.